-
Featured Press Release
Aspira Women’s Health Reports First Quarter 2021 Financial Results
Learn More -
Press Release
Aspira Women’s Health to Reveal 3rd Generation Ovarian Cancer Risk Assessment Technology at ASCO 2021
Learn More -
Press Release
Aspira Women’s Health Initiates Prospective Clinical Study for Benign Risk Monitoring and High Risk Early Ovarian Cancer Detection with Northwell Health®
Learn More
Recent News
Choose a Category:
-
Aspira Women’s Health Inc. to Report Second Quarter 2021 Financial Results on August 12
Press Release
Conference Call scheduled for Thursday, August 12th at 4:30 p.m. ET For a pdf of this press release please click here AUSTIN, Texas — July 27, 2021 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that it will report financial results for the second quarter ended June 30, 2021 on…
-
Aspira Women’s Health Inc. Announces Coverage for OVA1® in the AIM Specialty Health Laboratory Medicine Clinical Guidelines
Press Release
AIM is a member of the Anthem Blue Cross Blue Shield family of companies which promotes optimal care through use of evidence-based clinical guidelines and real-time decision support for both providers and their patients. AIM is a wholly owned subsidiary of Anthem, Inc., serving more than 50 million members across 50 states, D.C. and US…
-
Aspira Women’s Health Releases Analytical and Initial Clinical Validation Performance for OVASight at ASCO 2021
Press Release
For a PDF version of this press release, click here. Data demonstrates the performance of OVASight in a low prevalence population-89% Specificity, 91% Sensitivity and a Negative Predictive Value of 99.6%for the management of suspected Benign Pelvic Masses AUSTIN, Texas; June 3, 2021 – Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company focused on…
-
May is Mental Health Awareness Month
By: Diane Powis, Ph.D.
Blog
COVID-19 has had a profound impact on the mental health of so many people of all ages. Women diagnosed with ovarian cancer also face an increased risk of mental illness. In fact, according to a recent study, “Women diagnosed with ovarian cancer were more than three times more likely than the general public to be…
-
Aspira Women’s Health Inc. to Participate in the William Blair Growth Stock Conference
Press Release
For a PDF of this press release, click here. AUSTIN, Texas — May 19, 2021 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that management will participate in and present at the William Blair Growth Stock Conference on June 1-3, 2021. Details for the event are below: William Blair…